Entropy Neurodynamics

Entropy Neurodynamics LT Debt/Equity

Long-Term Debt to Equity Ratio of Entropy Neurodynamics (ENP.AX) as of Nov 22, 2026.

LT Debt/Equity

0.00

Last updated:

Long-Term Debt to Equity Ratio of Entropy Neurodynamics is 2025 0.00 . Long-Term Debt to Equity Ratio of Entropy Neurodynamics was 2024 0.00 . It decreases by % lower compared to the previous year.

The Entropy Neurodynamics LT Debt/Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

LT Debt/Equity
Date
LT Debt/Equity
Jan 1, 2023
0.00 AUD
Jan 1, 2024
0.00 AUD
Jan 1, 2025
0.00 AUD
The Entropy Neurodynamics LT Debt/Equity history
YEARLT Debt/EquityYoY
0.00—
0.00—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Entropy Neurodynamics Stock analysis

What does Entropy Neurodynamics do? Entropy Neurodynamics Ltd develops and commercializes exosomes as therapeutic agents. The company holds intellectual property related to exosome technology and offers LEAP manufacturing, LOAD API loading, and EVPS tropism technologies. Pharmaceutical and biotechnology companies purchase these proprietary technologies to enhance their own exosome-based products. The firm invests in biopharmaceutical drug development and leverages its portfolio of know-how to support partners in exosome medicine development. Exopharm Ltd. is the company's brand name, and it operates through its exosome technology portfolio. The firm's technologies solve key challenges in exosome medicine success, including manufacturing efficiency and targeted delivery. Biopharmaceutical companies are the primary buyers of these technologies, seeking to integrate exosome delivery systems into their therapeutic pipelines. The company's business model centers on licensing its exosome-related IP and know-how to pharmaceutical and biotech firms. By providing LEAP, LOAD API, and EVPS technologies, Entropy Neurodynamics enables partners to overcome technical barriers in exosome-based drug development. This approach generates revenue through technology licensing agreements with industry partners. Entropy Neurodynamics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Entropy Neurodynamics stock

On Eulerpool you can find the complete historical development of Long-Term Debt to Equity Ratio Entropy Neurodynamics since 2006 – with annual values, charts, and detailed analysis.

The LT Debt/Equity ratio measures long-term financial leverage. It shows how much permanent debt capital is used relative to equity financing.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Long-Term Debt to Equity Ratio's Entropy Neurodynamics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Entropy Neurodynamics

All Key Metrics — Entropy Neurodynamics